Chemomab Therapeutics Presents Data Reinforcing the Clinical

/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare...

Related Keywords

Israel , Vienna , Wien , Austria , Barbara Lindheim , Wadi Mor , Raanan Greenman , Rifaat Safadi , Avi Katav , John Lawler , Homer Levi , Douglas Thorburn , Chris Cirillo , Irina Koffler , Matthew Frankel , Shelia Sherlock , Tom Snir , Christopher Bowlus , Ilan Vaknin , Massimo Pinzani , Hepatology At University College London , Prnewswire Chemomab Therapeutics Ltd , Digestive Health , Institute For Liver , Data Monitoring Committee , Strategic Communications , Nasdaq , Lifesci Advisors , Chemomab Therapeutics Ltd , New Proteomics Data Further Confirms , Sclerosing Cholangitis , Provides Further Evidence , Inflammatory Disease Processes Driven , Elevated Levels , Annual Congress , European Association , Chief Executive Officer , Chief Scientific Officer , Shelia Sherlock Chair , University College , Revital Aricha , Palak Trivedi , Christina Crater , Private Securities Litigation Reform , Sci Advisors , Vice President ,